We are investigating Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) relating to the sale of the Company to Kohlberg Kravis Roberts & Co. L.P. (“KKR”). Under the terms of the proposed transaction, Envision shareholders are only anticipated to receive $46.00 for each share of Envision common stock held.